These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 2482158

  • 1. [Changes of T lymphocyte subsets in BERH-2 hepatoma-bearing rats and effect of different immunotherapies on the tumor].
    Guo YJ.
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):168-71. PubMed ID: 2482158
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ, Codde JP, Van der Meide PH, Gray BN.
    Anticancer Res; 1996 May; 16(3A):1145-54. PubMed ID: 8702226
    [Abstract] [Full Text] [Related]

  • 7. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.
    Geutskens SB, van der Eb MM, Plomp AC, Jonges LE, Cramer SJ, Ensink NG, Kuppen PJ, Hoeben RC.
    Gene Ther; 2000 Aug; 7(16):1410-6. PubMed ID: 10981668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Anti-tumor activity of peripheral lymphocytes of tumor-bearing rats by in vitro culture].
    Horie K, Yamasaki T, Nishimura K, Tsuchiya S, Yoshizawa A, Akimoto R, Watanabe H, Shirasawa K, Suzuki M, Tsujimoto Y.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1269-75. PubMed ID: 6233938
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A basic study on the anti-tumor activity of peripheral lymphocytes of tumor-bearing rats by in vitro culture].
    Horie K.
    Nihon Geka Gakkai Zasshi; 1985 Jul; 86(7):787-801. PubMed ID: 2931583
    [Abstract] [Full Text] [Related]

  • 15. Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.
    Mulé JJ, Yang JC, Afreniere RL, Shu SY, Rosenberg SA.
    J Immunol; 1987 Jul 01; 139(1):285-94. PubMed ID: 3108401
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antitumor effect of IL-2 entrapped in liposomes on rat hepatoma, AH-66].
    Konno H, Toriyama H, Aoki K, Baba S, Sakaguchi S, Yamashita A, Tadakuma T.
    Gan To Kagaku Ryoho; 1989 Jan 01; 16(1):53-8. PubMed ID: 2783545
    [Abstract] [Full Text] [Related]

  • 19. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    Cancer Res; 2001 Oct 15; 61(20):7563-7. PubMed ID: 11606395
    [Abstract] [Full Text] [Related]

  • 20. [Experimental study of the anti-tumor effects of directly administered packaging cell line of retroviral vector carrying IL-12 gene on hepatoma].
    Yang J, Qian Q, Xue H.
    Zhonghua Yi Xue Za Zhi; 1999 Oct 15; 79(10):761-3. PubMed ID: 11715523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.